johnepm Profile Banner
Juan Paredes Profile
Juan Paredes

@johnepm

Followers
440
Following
15K
Media
80
Statuses
1K

Gastroenterólogo del Hospital Nacional Guillermo Almenara Irigoyen Lima-Perú. Ex-Presidente de ASPEIN.

Lima
Joined October 2010
Don't wanna be here? Send us removal request.
@johnepm
Juan Paredes
11 months
Buenas tardes estimados amigos. Anunciamos la próxima realización del ECCO Workshop en Lima el 29 de agosto del 2025. Evento organizado por ASPEIN y ECCO. Gracias ⁦⁦@manu_barreiro
3
9
32
@johnepm
Juan Paredes
5 days
Efficacy and Safety with Upadacitinib by Baseline Corticosteroid Use in Patients with Moderately to Severely Active Crohn’s Disease
Tweet card summary image
academic.oup.com
AbstractImportance and Objective. Upadacitinib, an oral, reversible Janus kinase inhibitor, is approved for the treatment of moderate-to-severe Crohn’s dis
0
1
3
@IBDJournals
IBDJournal & CC360
6 days
Upadacitinib trials in CD show: 1️⃣ ⬇️ corticosteroid dependen 2️⃣ achieved clinical remission & ⬆️ QoL 3️⃣ promoted healing of intestinal tissue >2 yrs Read more about this promising long-term tx option that can ⬇️ patient reliance on corticosteroids.🙌 https://t.co/WLE6Hr4aHe
Tweet card summary image
academic.oup.com
AbstractImportance and Objective. Upadacitinib, an oral, reversible Janus kinase inhibitor, is approved for the treatment of moderate-to-severe Crohn’s dis
0
2
10
@KMonkemuller
Klaus Mönkemüller, MD, PhD
10 days
☢️ Computed Tomography Imaging and Cancer Risk - it’s there ✅ Let’s be more judicious about ordering a CT scan https://t.co/883JpEl2jm
Tweet card summary image
jamanetwork.com
This risk model projects how many future cancers in the United States could result from annual computed tomography examinations.
0
8
20
@bicentenario_p
Bicentenario
18 days
Recontra feeling , si estás sensible no lo escuches.
6
158
1K
@AlexElford3
Alex Elford
19 days
Nice talk from Bram Verstockt #icius Congress - IUS and histology clearly demonstrate that UC is a transmural disease - exciting future for delineating inflammatory va fibrosis stricture - submucosal layer predicts treatment response in UC
0
1
3
@johnepm
Juan Paredes
22 days
Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis
Tweet card summary image
journals.sagepub.com
Background: Infliximab (IFX) and vedolizumab (VDZ), frequently used biologics in inflammatory bowel disease (IBD), are available as intravenous (IV) and subcuta...
0
0
0
@pancco_org
PANCCO
23 days
https://t.co/MaGk6KszYb Los invitamos al Webinar con los doctores Kotze y Ernest. Próximo Martes 4/11/25 19:00 (GMT -5)
0
3
0
@johnepm
Juan Paredes
28 days
Spatial transcriptomics reveals unique inflammatory signatures across all anatomic locations in post-operative crohn’s disease | Journal of Crohn's and Colitis | Oxford Academic
Tweet card summary image
academic.oup.com
AbstractBackground and Aims. Most patients with Crohn’s disease (CD) who have undergone ileocolonic resection experience recurrent inflammation within one
0
2
5
@pakotze
Paulo G. Kotze
29 days
Out now at @UEGJournal the global perspective of pregnancy and lactation in IBD patients. https://t.co/E5kDCihaHd @geteccu Outstanding work from Maria Jose Casanova and Maria Chaparro.
1
8
24
@pancco_org
PANCCO
30 days
Congratulations to Dr. Fabián Juliao (@pancco_org President) and Dr. @pakotze for be part of the first ECCO Global Taskforce. #LATAM @Y_ECCO_IBD
1
3
11
@JulioIglGar
Julio IglesiasGarcia
1 month
4-6 march 2026, EUROEUS is back in Santiago de Compostela
0
1
7
@owleyesacademy
Owl Eyes Academy
2 months
🟢 Abierto el plazo de inscripciones para el Curso de Capacitación en Cápsula Endoscopica 2026. 👉 Edición España: Enero - Mayo. 👉 Edición LATAM: Febrero - Junio. 💊 Inscripciones e info en https://t.co/TnMTAbcwyd #owleyesacademy #capsulaendoscopica #capsuleendoscopy
0
3
7
@AcordesEII
Acordes por la EII
2 months
Hoy hemos vivido un momento lleno de magia en la pausa del congreso #GETECCU25, cuando cinco médicos participantes en el mismo han sorprendido a los asistentes interpretando Let it be, junto al saxo de Manuel de Haro, director de la @EmmAlcorcon 💜👇
1
8
18
@johnepm
Juan Paredes
2 months
Revised Guidelines for the Treatment and Follow‐Up of Gallbladder Polyps Do Not Reduce Unwarranted Cholecystectomies: Results of the POLYP Study - Dooren - 2025 - United European Gastroenterology Journal - Wiley Online Library
Tweet card summary image
onlinelibrary.wiley.com
Background Gallbladder polyps are seen in up to 7% of adults and carry a low malignancy risk. Guidelines on indication for surgery and follow-up remain controversial because of regional differences...
0
0
0
@johnepm
Juan Paredes
2 months
Anti-TNF Therapies Promote a Proximal-to-Distal Healing Pattern in Moderate-to-Severe Ulcerative Colitis | Inflammatory Bowel Diseases | Oxford Academic
Tweet card summary image
academic.oup.com
AbstractBackground. Ulcerative colitis (UC) is a chronic inflammatory disease of the colonic mucosa, extending proximally from the rectum. However, the seg
0
0
2
@johnepm
Juan Paredes
2 months
Muy merecido reconocimiento para una lumbrera de la gastroenterología, profesional completo y mejor persona @fgomollon !!!
0
3
15
@johnepm
Juan Paredes
2 months
El turno del Jedi Master @manu_barreiro en GETECCU 2025 debatiendo sobre disease clearance
2
1
12
@johnepm
Juan Paredes
2 months
La gran @yzabanaa inaugurando GETECCU 2025!!!!
1
1
9
@Efuentesval
Esteban FV
2 months
👩‍⚕️👨‍⚕️Reinduction or high dose maintenance therpay with upadacitinib in IBD? ➡️Prospective single center study ➡️patients responders to 45 mg induction ➕️ LOR ➕️ 45mg reinduction/maintenance ➡️46 patients underwent UPA Reinduction ➡️clinical response: 80.6%, ➡️CFSR: 71.7%
2
4
19